Medical Devices

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: CorriXR × InhaTarget × Merxin, inhaled CRISPR therapy for lung cancer

Lucid Diligence Brief: CorriXR × InhaTarget × Merxin, inhaled CRISPR therapy…

by Timos Papagatsias

Lucid Diligence Brief - Tech

Lucid Diligence Brief: Clairity's $43 million Series B for Clairity Breast

Lucid Diligence Brief: Clairity's $43 million Series B for Clairity Breast…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: ENA Respiratory Series B for Intranasal INNA-051

Lucid Diligence Brief: ENA Respiratory Series B for intranasal INNA-051…

by Timos Papagatsias

Artificial_Intelligence

Artificial Intelligence and Digital Health Weekly News - September 1st 2025

AI in Healthcare Update: Obesity, Heart & AI and more…

by Timos Papagatsias

Respiratory

Respiratory Weekly News - August 14th 2025

This Week in Respiratory Health: Global Respiratory Initiatives, CRISPR AMR…

by LucidQuest

Respiratory

Respiratory Weekly News - August 8th 2025

Respiratory & Pulmonary Health Updates: mRNA Asthma Therapies, AI-Powered…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.